Model
Edge
Nabriva Therapeutics
0001693064
Filing Type
4
Filing Date
1/30/2023
Updated
1/31/23, 1:56 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership